PBGH Announces Jumbo Employers' Top 5 Health Care Priorities
Learn what tops the health care agenda for PBGH members, the nation's largest employers that collectively spend $350 billion annually purchasing health care services for more than 21 million Americans and their families
Oakland, California, May 13, 2025 (GLOBE NEWSWIRE) -- Purchaser Business Group on Health (PBGH), a nonprofit coalition representing 40 private employers and public entities across the U.S., announced today the results of its member survey on top health care priorities. Cost control and affordability continue to top the list, with health insurance premiums climbing year after year and expected to increase by an average of 7% in 2025, outpacing inflation. Affordability is front and center for employers seeking to purchase care on behalf of their workforce. Rounding out the top five health care priorities are access to care; quality of care and appropriate utilization; RFPs/procurement of partners; and member experience and communications.
'These priorities should be a wake-up call for many health care stakeholders who think the status quo is acceptable,' explained Elizabeth Mitchell, President & CEO of PBGH. "We are not seeing serious efforts to contend with cost and affordability from the industry. But employers and families are paying the bills. Employers bear sole fiduciary responsibility for the health coverage they provide for employees and their families yet even getting access to price and quality data to effectively evaluate whether they are paying a fair price for health care services is still too hard.'
After affordability, members cite access to care, and quality of care as top concerns. Employers are using innovative strategies such as direct contracting, centers of excellence, integrated mental health in primary care, and using the PBGH Care Excellence Program to identify high-quality, affordable advanced primary care with high value specialty referrals. Employers are driving innovation absent industry solutions.
Many PBGH members planning RFPs during the coming year expressed heightened scrutiny on procurement processes to eliminate barriers to innovation and select aligned consultants and vendor partners.
Member experience and communications continue to remain a top five priority as benefits directors strive to provide employees with the best possible health benefits that meet employees' needs, keep employees and their families healthy, and make it easy to use health care services when they need it.
'The survey results affirm our strategic roadmap,' continued Mitchell. 'PBGH's strategic initiatives include programs that focus on affordable, high-quality, whole-person health, such as our Advanced Primary Care program and transparent data to establish fair pricing, ensure accountability and enable fiduciary success.'
Other priorities of interest cited in the survey include Consolidated Appropriations Act (CAA) compliance and legislative updates; data optimization for measuring benefits success; strategies for GLP-1 management; and continued interest in health equity, comprehensive cancer care, and employee well-being.
'While this survey marks the annual checkpoint with our members, we are in close contact throughout the year to ensure the resources, programs, services and education we develop are valuable to them,' explained Randa Deaton, PBGH's Vice President, Purchaser Engagement. 'It gratifying to gain deeper insights into their priorities and challenges and know we are helping to address them. There is power in collective action, and we expect to see more of that from employers in the future.'
About Purchaser Business Group on Health
PBGH is a nonprofit coalition representing nearly 40 private employers and public entities across the U.S. that collectively spend $350 billion annually purchasing healthcare services for more than 21 million Americans and their families. In partnership with its members, PBGH initiatives are designed to test innovative operational programs and scale successful approaches that lower healthcare costs and increase quality across the U.S.
###
CONTACT: Janet Cabibbo Purchaser Business Group on Health 9177510232 jcabibbo@pbgh.org
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
43 minutes ago
- Time Business News
Meet Your Trusted Dental Implant Specialist in Lake Mary
Are you missing one or more teeth and looking for a permanent, natural-looking solution? Dental implants may be the answer you've been searching for. But choosing the right professional makes all the difference. In this article, we'll walk you through everything you need to know about dental implants, what to expect, and—most importantly—how to meet your trusted dental implant specialist in Lake Mary who can restore your smile with confidence and precision. Dental implants are titanium posts that act as artificial tooth roots. Surgically placed into the jawbone, they fuse with the bone through a process called osseointegration, creating a stable foundation for replacement teeth such as crowns, bridges, or dentures. Compared to traditional tooth replacement methods like removable dentures or bridges, dental implants are more durable, comfortable, and functional. They prevent bone loss, maintain facial structure, and help you eat, speak, and smile naturally. According to the American Academy of Implant Dentistry , over 3 million Americans have dental implants, and that number is growing by 500,000 each year. As more patients discover the life-changing benefits of implants, the demand for skilled implant specialists continues to rise. You might benefit from dental implants if you have: One or more missing teeth Difficulty chewing or speaking due to tooth loss Jawbone deterioration from prolonged tooth absence An ill-fitting denture or bridge A desire for a permanent and aesthetically pleasing solution A comprehensive evaluation with a qualified specialist will determine if you're a candidate. This includes digital imaging, a review of your oral and medical history, and possibly bone grafting if you have low bone density. Understanding the procedure helps reduce anxiety and sets realistic expectations. Here's how it works: Your journey starts with a detailed consultation. The implant specialist will assess your oral health, bone density, and suitability for implants. A customized treatment plan is then developed. Under local anesthesia or sedation, the specialist surgically places the implant post into the jawbone. Healing typically takes 3–6 months, allowing the implant to fuse with the bone. Once healed, an abutment (connector) is attached to the implant. This part will hold your final crown, bridge, or denture. A custom-made crown or prosthesis is then attached to the abutment. Your new tooth will match your natural teeth in color, shape, and function. While many general dentists offer implants, a trusted dental implant specialist brings advanced training, experience, and technology to ensure better outcomes. Here's what sets them apart: Specialized Training: Periodontists and oral surgeons undergo additional years of education focused on implantology and oral surgery. Periodontists and oral surgeons undergo additional years of education focused on implantology and oral surgery. Precision Technology: Advanced tools like 3D imaging and guided surgery systems improve accuracy and reduce risk. Advanced tools like 3D imaging and guided surgery systems improve accuracy and reduce risk. High Success Rates: Specialists have higher implant success rates and are more adept at managing complex cases. When you choose to meet your trusted dental implant specialist, you're investing in the long-term success of your oral health and smile. Lake Mary is home to several dental professionals, but not all have the same level of expertise. Here's how to find the right fit: Look for board certifications, years of practice in implant dentistry, and memberships in professional organizations like the American Academy of Implant Dentistry (AAID) or the International Congress of Oral Implantologists (ICOI). A reputable specialist uses state-of-the-art technology such as CBCT scans, intraoral scanners, and digital treatment planning. Satisfied patients are a strong indicator of quality care. Check reviews and ask to see real results. Choose a clinic that offers everything from consultations to restoration under one roof for a seamless experience. If you're located in Central Florida, seeking dental implants Lake Mary ensures accessibility and continuity of care. Local specialists understand the needs of the community and are available for follow-ups, adjustments, or urgent issues without the hassle of long-distance travel. Choosing a Lake Mary-based specialist also supports your local economy and builds a lasting relationship with a provider who understands your dental history. One of the most common concerns is cost. Dental implants can range from $3,000 to $5,000 per tooth, depending on the complexity and materials used. However, many practices in Lake Mary offer: Flexible payment plans In-house membership discounts Financing through companies like CareCredit Insurance coordination, where applicable Always ask for a transparent cost breakdown and what's included (e.g., consultation, surgery, crown, imaging). Post-surgery care is crucial for healing and long-term success. Follow these tips: Stick to soft foods for a few days post-op Practice excellent oral hygiene, including gentle brushing and flossing Attend regular dental checkups and cleanings Avoid smoking or chewing hard objects Use any prescribed medications as directed Dental implants can last a lifetime with proper care, making them a worthwhile investment. Missing teeth can affect your appearance, confidence, and overall health. But you don't have to live with discomfort or insecurity. With the right guidance and expertise, you can reclaim your smile and quality of life. When you're ready to take the next step, meet your trusted dental implant specialist in Lake Mary. Their expertise, compassionate care, and cutting-edge approach will ensure that your journey toward a restored smile is smooth and successful. Ready to transform your smile with dental implants? Schedule your consultation with Lake Mary's leading implant specialist today. Discover a lifetime of confidence, comfort, and natural function with expertly placed dental implants. TIME BUSINESS NEWS
San Francisco Chronicle
2 hours ago
- San Francisco Chronicle
Letters: He overdosed after being turned away by S.F. drug treatment center. Mother seeks answers
Jonathan Martin, my son, overdosed after he was turned away from HealthRight360's detox facility on Aug. 27, 2024. Jonathan was desperately ill and seeking help. He died alone early the next morning. Jonathan's death was the subject of a Chronicle story ('He overdosed waiting for help. Why did S.F.'s largest drug treatment center provider turn him away?' San Francisco, Feb. 27). When the story was published, I sent a letter to Mayor Daniel Lurie, District Attorney Brooke Jenkins, the chiefs of the Department of Public Health and relevant agencies, HealthRight360 CEO Vitka Eisen and every member of the Board of Supervisors, hoping to find out why my son was turned away. I wanted to understand what prevented him from receiving the services he so urgently needed. I have still not received a single response, explanation or even a note of condolence from any of these officials. If the people who oversee drug treatment in the city will not answer a grieving mother, who will give my family answers? Citizens of San Francisco: You voted these people into office. Is this how you want your loved one to be treated while trying to seek help? The silence from those in power is deafening. Our family demands answers. Carolyn Stueve-Martin, Tulsa, Okla. Don't hide Pride I empathize with her desire for concealment, misdirection or camouflage during a time of danger. My wife is trans, and this is a scary time for us. But I am afraid that Judd is missing the purpose of Pride entirely. Pride is not about shame. It's not about showing off our most socially acceptable community members in the hopes that bigots will leave the rest alone. It is the bigots who should be ashamed. A Pride celebration that is ashamed of its trans and genderqueer members — who are, as Judd wrote, just people trying to live their lives openly and freely — is no Pride at all. Amanda Seyfer, Oakland Big Brother rising Technology has always been a double-edged sword. Fire can provide warmth and light, but it can also be used to burn down an enemy village. IBM's punch cards helped make Social Security possible, but also enabled Hitler's destruction of European Jewry. Today, a shadowy Bay Area company called Palantir is coalescing federal government information on Americans into a database that would allow it to target anyone who dissents from its autocratic policies or has characteristics that it does not favor. We need our representatives (or the courts) to block this monstrous machine before it rolls over us and makes this country a new Reich just like the old Reich.
San Francisco Chronicle
2 hours ago
- San Francisco Chronicle
New Alzheimer's blood tests make diagnosis easier — but they're not right for everyone
The number of Americans with Alzheimer's disease, the most common cause of dementia in the U.S., is projected to rise significantly in the coming decades. The devastating disease has no cure, but the past several years have brought promising developments in new drug therapies and blood tests that help doctors treat and diagnose the disease. Here's what to know about the blood tests that diagnose Alzheimer's, one of which got full FDA approval in May. How they work Several commercially available blood tests have become available the past few years, most recently from biotech company Fujirebio Diagnostics, which got full approval from the FDA last month. Each test measures slightly different things, but overall they look for abnormal levels of certain proteins — amyloid and tau — in the blood. The accumulation of amyloid and tau proteins in the brain, often called plaques, are hallmark signs of Alzheimer's. If someone has tau plaques in the brain, for instance, some of that will leak out of the brain into the blood, resulting in a blood test result showing higher than normal levels of tau. In patients with symptoms of cognitive impairment, the tests predict an Alzheimer's diagnosis with about 90% accuracy. Why they're important The blood tests are a notable development because they are less expensive and less invasive than other types of testing that doctors have long used to diagnose patients with Alzheimer's. One is a PET scan, which involves injecting a patient with a radioactive tracer that binds to amyloid or tau in the brain so the presence of the proteins can be seen in a scan. It can cost several thousand dollars, compared to several hundred dollars for a blood test. The other is a spinal tap, which is painful or uncomfortable for many people. This method measures different forms of amyloid and tau in the spinal fluid. 'Up until these blood tests came out, a physician was stuck doing a PET scan or spinal tap, so not great options,' said Dr. Frank Longo, a professor of neurology at Stanford Medicine. 'The big breakthrough is finding something to measure in the blood that's about 90% accurate of what's going on in the brain, about as accurate as spinal fluid or a PET scan.' Doctors use the blood test as part of a broader medical evaluation that also includes a patient history, neurological exam and other testing. The blood test can help rule out Alzheimer's as the cause of a patient's cognitive impairment and potentially avoid unnecessary further testing. If someone's blood test comes back normal, for example, they may not have to undergo the PET scan or spinal tap, and their doctor can look into other potential causes of the cognitive impairment. 'That's the biggest practical thing it's doing now,' Longo said. It's important to distinguish Alzheimer's from other types of dementia because there are Alzheimer's treatments that have come out the last few years that help slow the progression of Alzheimer's. But patients must be in relatively early stages of the disease, with mild impairment or mild dementia, to be eligible. Some of the therapies have significant side effects, so patients would not want to start them unless they knew it was Alzheimer's, and not something else, causing the dementia. They're not for everyone The tests are approved only for people who already have symptoms of cognitive impairment and are of a certain age — 55 and over or 60 and over, depending on the test. They are not approved for healthy adults with normal cognition who want to diagnose or rule out Alzheimer's, or who are simply curious if they are at risk for developing Alzheimer's. They must be ordered by a doctor. They're becoming more common, but may not be covered by insurance Some of the blood tests have been available for a year or two, Longo said, but they were under an earlier and more limited type of FDA approval, not the full approval that the agency granted last month to the Fujirebio test. So they are poised to become more common. 'A year ago, most of my colleagues and I were not ordering these,' Longo said. 'I'd say less than 5% or 10% of the time we were ordering these. Now people are starting to order them in symptomatic patients. It's not rare now. They're starting to be recognized more.' Some primary care doctors are starting to order the tests as well, said Dr. Armen Moughamian, medical director of Sutter Health's Ray Dolby Brain Center at CPMC in San Francisco. The center treats patients with memory disorders. 'It's definitely a minority, but I've been seeing it done,' he said. As with many new medical tests, insurers may not cover them yet, but that usually evolves over time. Full FDA approval may help make the case for the tests to be covered, Longo said. 'There is some uncertainty and lack of clarity about whether insurance and Medicare pay,' Moughamian said. 'That creates some hesitancy for providers to order it.' They may one day be used to screen and diagnose healthy people earlier In people with Alzheimer's, amyloid plaques begin to form in the brain as many as 20 years before they show symptoms. Right now, newer therapies for Alzheimer's — like lecanemab and donanemab, which slow the progression of the disease — are approved only for people with symptoms. Those symptoms are mild cognitive impairment or mild dementia, the early stages of symptomatic Alzheimer's. This means people who have not yet developed symptoms, but who have amyloid plaques in the brain, cannot get these treatments. So if a blood test could be used in pre-symptomatic people, it could mean better screening and earlier diagnosis to larger groups of people. 'What we want to push for is earlier diagnosis because new therapies are available when we catch people in earlier stages,' Moughamian said. Moughamian is leading two clinical trials that examine whether drugs that remove amyloid in the brain, donanemab and another drug remternetug, can work in people who have amyloid plaques but have not yet developed symptoms. They are using an Alzheimer's blood test to see whether patients are eligible for the trial.
